Show simple item record

dc.contributor.authorDonaldson, Stephanie B
dc.contributor.authorBonington, Suzanne C
dc.contributor.authorKershaw, Lucy E
dc.contributor.authorCowan, Richard A
dc.contributor.authorLyons, Jeanette
dc.contributor.authorElliott, Tony
dc.contributor.authorCarrington, Bernadette M
dc.date.accessioned2013-09-25T11:54:41Z
dc.date.available2013-09-25T11:54:41Z
dc.date.issued2013-08-15
dc.identifier.citationDynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect. 2013: Eur J Radiolen_GB
dc.identifier.issn1872-7727
dc.identifier.pmid24034835
dc.identifier.doi10.1016/j.ejrad.2013.08.008
dc.identifier.urihttp://hdl.handle.net/10541/302258
dc.description.abstractTreatment of muscle-invasive bladder cancer with chemotherapy results in haemorrhagic inflammation, mimicking residual tumour on conventional MR images and making interpretation difficult. The aim of this study was to use dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to estimate descriptive and tracer kinetic parameters post-neoadjuvant chemotherapy and to investigate whether parameters differed in areas of residual tumour and chemotherapy-induced haemorrhagic inflammation (treatment effect, Tr-Eff).
dc.languageENG
dc.language.isoenen
dc.rightsArchived with thanks to European journal of radiologyen_GB
dc.titleDynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect.en
dc.typeArticleen
dc.contributor.departmentSchool of Cancer and Enabling Sciences, University of Manchester, Oxford Road, Manchester M13 9PL, UK; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.en_GB
dc.identifier.journalEuropean Journal of Radiologyen_GB
html.description.abstractTreatment of muscle-invasive bladder cancer with chemotherapy results in haemorrhagic inflammation, mimicking residual tumour on conventional MR images and making interpretation difficult. The aim of this study was to use dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to estimate descriptive and tracer kinetic parameters post-neoadjuvant chemotherapy and to investigate whether parameters differed in areas of residual tumour and chemotherapy-induced haemorrhagic inflammation (treatment effect, Tr-Eff).


Files in this item

This item appears in the following Collection(s)

Show simple item record